(Total Views: 147)
Posted On: 02/27/2019 9:15:23 AM
Post# of 156928
Yes, I agree. The 120k price hopefully is just to bump the inventory price to 500M.
I like the 70k move, probably 50k-70k I feel is a good range. 50k is top end for HIV other than IZ.
The 120k matches IZ for the unmet need for HIV and also matched cancer, but no other hiv drug is close to 120k (see below). This might be another reason IZ is not selling well. Probably a hard sell to both mds and insurance companies.
I'm not sure how old this article is but 10k for a month's supply is way more than all listed here. For mono patients might switch from 3 drugs to 1 drug (leronlimab) and the price go up. Not good at all imo.
https://www.healthline.com/health/hiv-aids/co...drug-costs
I like the 70k move, probably 50k-70k I feel is a good range. 50k is top end for HIV other than IZ.
The 120k matches IZ for the unmet need for HIV and also matched cancer, but no other hiv drug is close to 120k (see below). This might be another reason IZ is not selling well. Probably a hard sell to both mds and insurance companies.
I'm not sure how old this article is but 10k for a month's supply is way more than all listed here. For mono patients might switch from 3 drugs to 1 drug (leronlimab) and the price go up. Not good at all imo.
https://www.healthline.com/health/hiv-aids/co...drug-costs
(0)
(0)
